B, S., GH, T., HW, B., JS, B., D, G., WM, S., . . . JG, B. (2009). Antimicrobial agents for complicated skin and skin-structure infections: Justification of noninferiority margins in the absence of placebo-controlled trials. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 49(3), 383. https://doi.org/10.1086/600296
Chicago Style (17th ed.) CitationB, Spellberg, Talbot GH, Boucher HW, Bradley JS, Gilbert D, Scheld WM, Edwards J. Jr, and Bartlett JG. "Antimicrobial Agents for Complicated Skin and Skin-structure Infections: Justification of Noninferiority Margins in the Absence of Placebo-controlled Trials." Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America 49, no. 3 (2009): 383. https://doi.org/10.1086/600296.
MLA (9th ed.) CitationB, Spellberg, et al. "Antimicrobial Agents for Complicated Skin and Skin-structure Infections: Justification of Noninferiority Margins in the Absence of Placebo-controlled Trials." Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America, vol. 49, no. 3, 2009, p. 383, https://doi.org/10.1086/600296.